These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa. Van Woert MH; Mueller PS Clin Pharmacol Ther; 1971; 12(2):360-7. PubMed ID: 5577484 [No Abstract] [Full Text] [Related]
3. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. Sirtori CR; Bolme P; Azarnoff DL N Engl J Med; 1972 Oct; 287(15):729-33. PubMed ID: 5056733 [No Abstract] [Full Text] [Related]
4. [Significance of disorders of glucose metabolism in diseases of the nervous system (author's transl)]. Glasner H Munch Med Wochenschr; 1973 Dec; 115(49):2225-8. PubMed ID: 4801588 [No Abstract] [Full Text] [Related]
5. Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease. Rosati G; Maioli M; Aiello I; Farris A; Agnetti V Eur Neurol; 1976; 14(3):229-39. PubMed ID: 1278195 [TBL] [Abstract][Full Text] [Related]
6. Dementia is associated with insulin resistance in patients with Parkinson's disease. Bosco D; Plastino M; Cristiano D; Colica C; Ermio C; De Bartolo M; Mungari P; Fonte G; Consoli D; Consoli A; Fava A J Neurol Sci; 2012 Apr; 315(1-2):39-43. PubMed ID: 22265943 [TBL] [Abstract][Full Text] [Related]
7. Abnormal insulin secretion in Parkinson's disease before and during L-dihydroxyphenylalanine (L-dopa) therapy. Van Woert MH; Mueller PS; Ambani LM; Rathey U J Endocrinol; 1973 Dec; 59(3):523-34. PubMed ID: 4761683 [No Abstract] [Full Text] [Related]
8. [Use of the oral glucose tolerance curve as a criterion for validating some indicators of risk of developing glucose intolerance]. González Bernal G; Avila Rosas H; Breña Flores H Rev Invest Clin; 1988; 40(3):259-64. PubMed ID: 3217617 [No Abstract] [Full Text] [Related]
9. Apomorphine increases blood glucose concentrations in Parkinson's disease. Tison F; Fouillet N; Henry P Clin Neuropharmacol; 1994 Feb; 17(1):92-5. PubMed ID: 8149364 [TBL] [Abstract][Full Text] [Related]
10. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa. Boyd AE; Lebovitz HE; Feldman JM J Clin Endocrinol Metab; 1971 Nov; 33(5):829-37. PubMed ID: 5125386 [No Abstract] [Full Text] [Related]